Abstract:Epigenetic marks such as DNA methylation and histone modifications are widely involved in regulating different aspects of developmental and environmental responses (1). Meanwhile, DNA methylation and histone modification are also used constitutively to silence transposable elements and repeat elements (TREs) (2). Such TRE-mediated silencing should necessarily be limited to the intended targets only and not spread to adjacent genes and their regulatory elements. Higher eukaryotic organisms have evolved antisilencing mechanisms to keep the balance between silencing and antisilencing that is required for precise gene expression regulation. Earlier work revealed that repressor of silencing 1 (ROS1) is one such antisilencing gene (3). Recently, a group of unique antisilencing genes has been discovered, including enhanced downy mildew 2 (EDM2) reported both by Lei et al. in PNAS (4) and earlier by Tsuchiya and Eulgem (5), anti-silencing 1 (ASI1) by Wang et al. (6), and increase in bonsai methylation 1 (IBM1) by Saze et al. (7). What distinguishes the latter group of genes from ROS1 is that they seem to be involved in posttranscriptional regulation through alternative polyadenylation (APA). Polyadenylation is an essential mRNA processing step for almost all genes in eukaryotes (8, 9). The poly(A) site defines the end of the transcript and thus its 3′-UTR. However, an alternate site of processing and poly(A) addition would create a different transcript by an inclusion or exclusion of certain RNA sequences such as the miRNA target site, a recognition site of an mRNA stability factor, or a translational repressor. In recent years, APA has been shown to change the fate of a cell or a developmental process and to alter cellular responses to the environment, including tumorigenesis, flowering time control, and oxidative responses (10⇓–12). Genomewide analyses by deep sequencing have revealed that 70–80% of human and plant genes are subject …

Implications of polyadenylation in health and disease

mRNA alternative polyadenylation (APA) in regulation of gene expression and diseases

Alternative Polyadenylation: Methods, Mechanism, Function, and Role in Cancer.

Alternative Polyadenylation of mRNAs: 3′-Untranslated Region Matters in Gene Expression

Alternative Polyadenylation of Mrna and Its Role in Cancer

Context-specific regulation and function of mRNA alternative polyadenylation

Alternative Polyadenylation: Methods, Findings, and Impacts

Interplay between splicing and transcriptional pausing exerts genome-wide control over alternative polyadenylation

Emerging Roles of RNA 3′-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders

RNA polyadenylation and its consequences in prokaryotes

Alternative Polyadenylation A Mechanism Maximizing Transcriptome Diversity In Higher Eukaryotes

Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Regulatory roles of N6-methyladenosine (m 6 A) methylation in RNA processing and non-communicable diseases

Role Of Alternative Polyadenylation In Epigenetic Silencing And Antisilencing

Genome-wide Identification and Predictive Modeling of Tissue-Specific Alternative Polyadenylation.

Regulatory Roles of N6-methyladenosine (m6a) Methylation in RNA Processing and Non-Communicable Diseases

Cleavage and polyadenylation factors are potential regulators of adipogenesis

Alternative polyadenylation and gene expression regulation in plants.

N6-methyladenosine-mediated Gene Regulation and Therapeutic Implications.

Advances of functional consequences and regulation mechanisms of alternative cleavage and polyadenylation